Moderat til alvorlig anæmi (grad 3 og 4 - Hb ≤ 8, 0 g/ dl) sås hos 25% af patienterne (12% af behandlingsperioderne).
Moderate to severe anaemia (Grade 3 and 4 – Hb ≤ 8.0 g/ dl) occurred in 25% of patients (12% of courses).